Annual Drug Patent Expirations for NEXTSTELLIS Nextstellis is a drug marketed by Mayne Pharma and is included in one NDA. It is available from one supplier. There are two patents…
Source
Annual Drug Patent Expirations for MAYZENT Mayzent is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are two patents protecting…
Source
Annual Drug Patent Expirations for ZEPBOUND Zepbound is a drug marketed by Eli Lilly And Co and is included in one NDA. It is available from one supplier. There are…
Source
Annual Drug Patent Expirations for MYCAPSSA Mycapssa is a drug marketed by Chiesi and is included in one NDA. It is available from two suppliers. There are twelve patents protecting…
Source
MYRBETRIQ GRANULES (mirabegron) Apgdi Patent: 7,982,049 Expiration: May 4, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
Source
Drug Patent Expirations for the Week of April 28, 2024 Read Post »
This chart shows the drugs with the most patents in Japan. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
Source
Which pharmaceutical drugs have the most drug patents in Japan? Read Post »
Annual Drug Patent Expirations for TAVNEOS Tavneos is a drug marketed by Chemocentryx and is included in one NDA. It is available from one supplier. There are three patents protecting…
Source
Annual Drug Patent Expirations for OTEZLA Otezla is a drug marketed by Amgen Inc and is included in one NDA. It is available from one supplier. There are three patents…
Source
Annual Drug Patent Expirations for LUTATHERA Lutathera is a drug marketed by Aaa Usa Inc and is included in one NDA. It is available from one supplier. There are two…
Source
Annual Drug Patent Expirations for DURYSTA Durysta is a drug marketed by Abbvie and is included in one NDA. It is available from one supplier. There are nine patents protecting…
Source